This work compares equilibrium to kinetic analy sis of positron emission tomography data for the assessment of vesicular monoamine transporter (VMAT2) binding density us ing (+)-a-C lCldihydrotetrabenazine «+ )-a-[11ClDTBZ). Stud ies were performed for 80 minutes after intravenous adminis tration of 18 ± f mCi (+ )-a-[ II ClDTBZ on 9 young control subjects, 20 to 45 years of age. A 9-mCi bolus was injected over the first minute of the study, whereas the remaining 9 mCi were infused at a constant rate over the following 79 minutes. Steady-state was reached in both blood and brain by approxi mately 30 minutes after initiation of the study. Nonlinear least squares analysis using two-and three-compartment models, weighted integral analysis using a two-compartment configu ration, and Logan plot analysis all yielded kinetic estimates of the total tissue distribution volume, DV' OI (kin)' These results were compared with equilibrium distribution volume estimates, DV,o,(eq)' calculated from the tissue to metabolite corrected arterial plasma concentration ratio after 30 minutes. Kinetic modeling results from this study were in close agreement with This study assesses the capabilities of using (+ )-a [ l 1 C]dihydrotetrabenazine « + )-a-e I C]DTBZ) and an equilibrium positron emission tomo graphy (PET) proto col for estimating binding to the vesicular monoamine transporter (VMAT2) in the human brain. The VMAT2
lipophilic metabolites, have been developed and used for human imaging. Studies have demonstrated that in vivo regional binding of these radioligands correlates with the known distribution of VMA T2 in rodent brain (Kilbourn, 1994; Kilbourn et aI., 1995) , and that a linear relation exists between the level of in vitro striatal radioligand binding to VMAT2 and the extent of nigral injury in 6-hydroxydopamine�lesioned rats (Vander Borght et a!., 1995b) . The <x-DTBZ exhibits high-affinity binding only to VMA T2, and animal studies have shown a lack of regulation of 'this transporter by repeated or chronic do paminergic or cholinergic drug treatmen � s (N audon et aI., 1994 , Vander Borght et aI., 1995a Wilson et aI., 1996) . Although <x-DTBZ binding is not specific to do paminergic nerve terminals, since the radioligand binds to the vesicular transporter common for all monoamin ergic neurons, the PET signal measured in the striatum largely represents storage vesicles in the predominant (over 95%) dopaminergic terminals (Kish et aI., 1992 ) .
In this work, we describe methods of analysis of PET studies with (+) -<x-[ " Cjdihydrotetrabenazine for quanti fying levels of binding to the vesicular monoamine trans porter. Preliminary studi es used a racemic mixture of th e radioligand (±) -<x-[ " CjDTBZ (Koeppe et aI., 1995; Frey et aI., 1996; Gilman et aI., 1996) . However, the (-) isomer has an extremely low affinity (about 2 fLmollL) for the VMAT2 binding site (Kilbourn et aI., 1995) , and thus the binding is almost exclusively nonspecific, add ing noise but no signal to the measure. Se paration of the isomers allows administration of th e active isomer (+) <x-[ " CjDTBZ (Ki = 0. 97 ± 0. 48 nmollL; Kilbourn et aI., 1995) alone, substantially increasing the signal to back ground of the VMAT2 binding measures. Dynamic PET studies in normal volunteers using bolus injections of (+)-<x-[ l' C]DTBZ have been analyzed using a variety of compartmental model configurations and parameter es timation schemes (Koeppe et aI., 1996) .
Here we present a comparison of an equilibrium analysis of (+ )-<x-[ 'l C]DTBZ with the kinetic analysis methods reported by Koeppe and coworkers (1 996) for the estimation of a VMA T2 binding density index after a single radioligand injection. The kinetic approach re quires about an hour of dynamic imaging as well as arterial plasma and metabolite analysis throughout th e entire study. An equilibrium or steady-state approach re quires acquisition of only a few scans and analysis of only a few blood samples after equilibrium conditions are achieved (about 30 minutes), and thus a considerably simpler and better tolerated protocol can be used. In this study, a more complex data acquisition protocol was used so that both kinetic and equilibrium analyses could be evaluated. However, equilibrium analysis by itself requires only about 30 minutes of imaging and two or three blood samples.
Equilibrium approaches have been proposed and used extensively for tracers that bind reversibly and equili brate relatively rapidly, such as e l Cjrac10pride (Farde et a!., 1986 , 1987 , Minoshima et aI., 1994 , [ ll Cjflumazenil (Persson et aI. , 1985 (Persson et aI. , , 1989 Shinotoh et aI., 1986 Shinotoh et aI., , 1989 Pappata et a!. , 1988 , Frey et aI., 1993 , and e 8 F]cyclo foxy (Kawai et aI. , 1991) . Some of these have used con tinuous-infusion protocols to ensure that true equilibrium conditions between arterial plasma and brain are estab lished (Kawai et a!., 1991; Frey et aI., 1993; Minoshima et a!., 1994) , whereas the others are pseudoequilibrium approaches, where a bolus injection is given and scan ning is performed under conditions that may approach, but do not reach, true equilibrium. To achieve equilib rium as rapidly as possible, we determined an infusion protocol consisting of a partial bolus to "load" the tis sue, followed by continuous administration of the re mainder of the dose to achieve and maintain steady-state conditions. In addition, we were interested in evaluating the measured uncertainties in the distribution volume es timates to see whether the simpler calculation afforded by the equilibrium approach provides more stable bind ing estimates than do the kinetic approaches.
METHODS
Nine young normal volunteers, aged 20 to 45 years, were studied after administration of 666 ± 37 MBq (18 ± I mCi) of (+)-a-[ II C]DTBZ. A dose of 333 MBq (9 mCi) was adminis tered by intravenous bolus injection over the first minute of the study, whereas the remaining 333 MBq were continuously in fused over the remaining 79 minutes of the study. The 50:50 fractionating between bolus and infusion portions of the dose was based on calculations of the clearance rate from plasma from previous bolus studies see Discus sion) . No-carrier-added (+ )-[ l I C]DTBZ (250 to 1000 Cilmmol at time of injection) was prepared, as reported by Jewett and others (1997) . A sequence of 17 PET scans (4 x 30 seconds, 3 x I minute, 2 x 2.5 minutes, 2 x 5 minutes, 6 x 10 minutes) was acquired in two-dimensional mode on a Siemens/Cn ECA T EXACT-47 scanner (Knoxville, TN) for 80 minutes after in jection. Data were reconstructed using a Hanning filter with a cutoff of 0.5 cycles/projection ray, achieving a reconstructed resolution of about 9 mm full-width at half-maximum. Calcu lated attenuation correction was perfonned on all data sets.
Blood samples were withdrawn using a radial artery catheter at 10-second intervals for the first 2 minutes and then at pro gressively longer intervals for the remainder of the study. Plasma was separated from red cells by centrifugation and counted in a NaI well-counter. The plasma radioactivity time course was corrected for radiolabeled metabolites using a rapid Sep-Pak C I 8 cartridge chromatographic technique similar to that previously reported for scopolamine and flumazenil (Frey et a!., 1991; . The samples at 1, 2, and 3 minutes and at all later times (13 in all) were analyzed for metabolites. Ali quots of 0.5 mL of plasma were added to tubes containing and 0.6 mL of a solution of eHlDTBZ (0.002 mCi) in phosphate buffered saline. After application to Sep-Pak C IS columns, samples were first washed with 9 mL of a 65: 35 mixture of phosphate-buffered saline�thanol. This fraction contained all metabolites and a portion of the authentic DTBZ. The remain der of the unmetabolized fraction then was eluted from the column with 5 mL of ethanol. Both samples were assayed for IlC activity in the well counter, and then after decay of II C, assayed for 3H by liquid scintillation counting. The fractionat ing of [3HlDTBZ (100% authentic) was used to correct for the portion of authentic e IClDTBZ eluted in the first wash. Me tabolite fractions of the samples not analyzed for metabolites were estimated by linear interpolation. Previous studies re ported by Frey and colleagues (1996) showed no measurable levels of DTBZ metabolites in the rat brain, even at 80 minutes after injection.
Radioactive fiducial markers were used to correct for patient motion that occurred throughout the study. Molecular sieve beads (1-to 2-mm diameter) were placed at three points on the patient ' s scalp before the study. Approximately I JLL of the [llC]DTBZ preparation was pipetted onto each bead at an ac tivity of about 2 JLCi per bead. Bead locations defined on a single base frame (frame 10; 10 to 15 minutes after injection) were used for reorientation of the other frames of the study as described by Koeppe and colleagues (1991) .
Volumes-of-interest were created on the base frame and ap plied to the entire dynamic sequence generating time-activity curves for the different brain structures. Regions analyzed in cluded caudate nucleus, putamen, frontal cortex, thalamus, and cerebellar hemispheres. Left and right hemisphere regions were analyzed separately then averaged within each subject before calculation of group means and standard deviations. No sig nificant hemispheric differences were detected.
Dynamic studies were acquired for comparing equilibrium and kinetic analysis techniques in the same set of PET studies. In addition, we compared results of the kinetic analysis from this constant infusion study to those from our previously re ported study (Koeppe et aI., 1996) , which used bolus adminis trations. This was to assure that changes in input function shape did not affect our ability to estimate model parameters in a dynamic study.
Equilibrium analysis
Estimates of DV,ot(eq) were obtained by dividing the concen tration of (+ )-a-lllClDTBZ in tissue (measured with PET) by the metabolite-corrected arterial plasma concentration averaged over the portion of the study after equilibrium conditions were achieved: DVtot(cq) = CP E T/Cp' For calculation purposes, CP E T and Cp were assumed to be constant over the entire "equilib rium" period and averaged over time before calculating their ratio. Both tissue and blood data remained nearly constant 30 minutes after administration, and hence data after 30 minutes were used in calculation of DVtot(cq)' Five IO-minute scans were acquired between 30 and 80 minutes after the initiation of tracer administration. Plasma samples were withdrawn every 10 minutes throughout this period to determine the level of authentic (+ )-a-e IClDTBZ. Calculations were performed us ing two time intervals: 30 to 60 minutes and 30 to 80 minutes. The final 20 minutes of scanning is more certain to be acquired during steady-state conditions, although the 20-minute physical half-life of I I C limits the statistical quality of these later data.
Kinetic analysis
Four separate kinetic analyses were performed on the dy namic data as described by Koeppe and others (1996) . In this previous work, it was determined that DV,ot provided the most reliable index of VMAT2 density. Nonlinear least-squares analysis using the Marquardt algorithm (Bevington, 1969) was performed with both two-and three-compartment model con figurations on the volumes-of-interest-generated time activity data to estimate DVtot' For the two-compartment configuration, K I , DVto" and CBV were estimated, whereas for the three-compartment configuration, K I , DVr+n" k 3 ' k4' and CBV were estimated (for details, see Koeppe et aI., 1996) . Two pixel-by pixel analyses also were performed on the dynamic data sets: a two-parameter weighted integral analysis (Alpert et aI., 1984) producing functional images of ligand delivery (K I ) and bind ing (DV , o'(ki n»' and a graphic analysis for reversible ligands (Logan et aI., 1990 ) also calculating DVtot(kin) (from data 10 minutes and later) and an approximation for K I (using the entire data set). Again, further details of the implementation of these methods are given in Koeppe and others (1996) . After creation of K I and DVtot(kin) images for both the weighted integral and Logan plot methods, the volumes-of-interest de fined for nonlinear least-squares analysis were applied to the functional images to obtain regional parameter estimates. As with the equilibrium analysis, data over two different scan du rations were analyzed: 0 to 60 minutes, and 0 to 80 minutes. Estimates from each of the kinetic methods (DV' U l(kinj) were compared with those from the equilibrium method (DV'ot(eq» for both the 60-and 80-minute analyses. For least-squares analysis, data were weighted according to the raw number of detected events per frame, whereas for other methods, data weighting was not employed.
RESULTS
Steady-state conditions in plasma and all tissue com partments are required for equilibrium analysis to be valid. Our first objective was to verify that steady-state conditions could be reached in both blood and brain within a reasonable time. Figure 1 shows the arterial plasma activity over the 80 minutes' duration from a typical study. Both the total activity in plasma, uncor rected for radiolabeled metabolites, and the activity of authentic 
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.1 consists of a partial loading bolus of 50% of the dose (9 mCi) delivered over the first minute of the study followed by continuous infusion of the remainder of the dose (9 mCi) over the remaining 79 minutes of the study. Values have been corrected for radio active decay. Equilibrium in blood is reached by 20 to 30 minutes into the study.
(+) -a-e I CJDTBZ was administered as a "loading" bo lus over the fi rst 60 seconds of the study, fo llowed by continuous infusion of the remaining 9 mCi over the fi nal 79 minutes of the study. These values are corrected for radioactive decay, and thus the actual injected dose of (+ )-a-[ II C]DTBZ during the continuous-infusion phase of the scan is substantially less than 9 mCi. By about 20 minutes after the initial priming bolus, the concentration of both total radioactivity and, more importantly, authen tic (+)-a-[ II C]DTBZ radioactivity had re ached a nearly constant level (typically 0.05 to 0.1 fLCi imL). The total radioactivity in the form of radiolabele� metabolites at equilibrium averaged 44% ± 7% across the nine subjects (r ange 31 % to 53% ). Figure 2 shows tissue time-activity curves for the same study. The (+)-a-[ II C]DTBZ tissue concentration values for each of the five regions ana lyzed in this study are plotted at the mid-time for each scan frame . The authentic plasma activity curve from Fig. 1 is plotted on the same scale for comparison (solid curve). Tracer retention was highest in the basal ganglia, reaching steady-state levels around I fLCiimL, whereas steady-state values in the other br ain regions averaged about a third as high. The degree to which equilibrium was achieved in both plasma and tissue is demonstrated in Fig. 3 , which shows group mean and standard devia tions for later time points in the scans. The group trend was for slight increases in tracer concentration in both arterial plasma and brain. The mean and standard devia tions of the slope given by linear regression of the tracer concentration over the final 50 minutes of the study for individual subjects were +O.lO ± 0.1 8% per minute from 30 to 80 minutes in plasma (or a 4.8% increase over the entire 50-minute period), +0.05 ± 0.14% per minute in
.66 6 E 6 l! :::: : Brain radioactivity concentration time course for equilib rium studies. Plotted are the tissue time-activity curves for five brain regions over the ao minutes' study duration. The adminis tration is the same as described in Fig. 1 . Values have been corrected for radioactive decay. Equilibrium is reached in all re gions by 30 to 40 minutes into the study.
J Cereb Blood Flow Metab, Vol. 17, No.9, 1997 FIG. 3. Stability of plasma and brain radioactivity concentration at equilibrium. Shown are the group mean and standard deviation of concentration values for both metabolite corrected arterial plasma (top) and brain regions with both high and low binding (bottom) during the equilibrium phase of the study. All data sets (plasma, cortex, putamen) for each of the nine subjects were normalized to the mean concentration measured over the 30-to aO-minute period. Thus, values over the entire time period aver ages 1 for not only the group but each individual subject.
brain regions with high binding (putamen), and +0.09 ± 0.1 1 % per minute in brain regions with low binding (frontal cortex). Six of nine subjects showed slight in creases in plasma concentration over time whereas three of nine (i ncluding the subject shown in Figs. I and 2) showed slight decreases. Regional tissue concentration typically showed the same trend as that in plasma. In individual subjects, variability across the equilibrium pe riod, as given by the standard deviation of the measured tracer concentrations over the final 50-minute period, ranged from 4% to 12% for plasma and 2% to 7% fo r all brain regions examined. A second objective was to verify that the change in input function shape for infusion studies compared with bolus injection studies did not cause differences in the kinetic estimates of VMA T2 binding . Figure 4 presents DVtot(kin) estimates using the pixel-by-pixel weighted in tegral analysis with 60 minutes of data for the current continuous infus ion study (n = 9; solid bars) compared with those from our previous bolus injection study (n = 7; shaded bars). Shown are the mean and standard de viation of each group for the five regions analyzed. No statistically significant differences were detected in any of the five regions (P > 0.2 5). Similar results were ob tained for the other kinetic methods, which also yielded no statistically significant differences between bolus and continuous infusion studies.
Our third and primary objective in this study was to comp are estimates of VMA T2 binding from equilibrium analysis with those from kinetic analyses of the same data sets. Table 1 reports group mean and standard de viations of DVtot for each of the methods using data to 60 minutes. Coefficients of variation were approximately 20% and found to be nearly identical both across meth ods and across regions . Also given are the group mean and across subjects standard deviation of the percent dif ference between each of the kinetic methods and the equilibrium method. A two-factor repeated measures analysis of variance was performed with method and region as repeated measures. The analysis included a method by region interaction term. Since the across sub je cts standard deviations were not equivalent for the dif ferent regions but proportional to the regional means (i.e., equal regional coefficients of variation), a logarith- mic transformation of DVtot was used to stabilize the variances. Re sults indicate that there were significant dif ferences across analysis methods (P < 0. 0001) as well as the known differences across regions (P < 0.0001). In addition, a significant region by method interaction (P = Table 1 . The uniformity of th e coefficients of variation across analysis methods indicates there is not likely to be major differences in precision of DVto, between the methods; however, intersubj ect variability, if high, may mask smaller intermethod differences in precision. Since th e true values � or DVtot are not known, the precision of the methods is not readily determined. One indicator of pre cision is to look at the functional imagys created from pixel-by-pixel estimations of DV,o, for th e various meth ods. Fi gure 5 shows pixel-by-pixel DVtDt images at three different brain levels created by th e weighted integral, Logan plot, and equilibrium methods. Th e left two col umns show weighted integral and Logan plot DV I D I es timations from one of the seven bolus inj ec tion studi es included in the data pres ented in Fi g. 4. The right three columns show weighted integral, Logan plot, and equi librium DVtDt estimations for a typical bolus-plus infusion scan from th e current study. The top row of images are shown at a level through the caudate nucleus and putamen and are windowed to show th e full dynamic range of DVtot in DTBZ studies. The following rows show three brain levels windowed down by a factor of 3. 0 to highl fg ht areas of low binding. Row 3 shows th e same brain levels as row I, whereas rows 2 and 4 show slices approximately 3.5 em higher and 3.5 em lower, respectively, than those in row 3. Effects of differing administration protocols (bolus versus bolus-plus infusion) can be seen by examining columns I and 2 compared with columns 3 and 4. Effects of kinetic versus equilibrium analysis methods applied to the same set of data can be examined by comparing columns 3 through 5.
Two independent observers rated the statistical quality of DVtD I image sets for each of the seven bolus inj ection subjects and each of the nine bolus-plus-infusion sub jects. Both observers rated the DVtDt images from the bolus studies to be slightly superior on average to those from the bolus-plus-infusion subjects for both weighted integral and Logan plot methods. There was considerable overlap, but the three highest rated images sets were from bolus studies, whereas the four lowest rate sets were from bolus-plus-infusion studies. Differences in statistical quality betw een the weighted integral, Logan plot, and equilibrium methods within the bolus-plus infusion group were judged to be minimal, with no con sistent preference for any one method.
The region by method interaction mentioned above can be appreciated better by ex amining th e ratio between high and low binding regions, as seen in Table 2 , where group means and standard deviations are reported for DVtD I normalized to frontal cortex. Coefficients of varia tion for the normalized binding estimates were consid er ably smaller than those for th e absolute estimates, the usual finding in most PET studies . Also given are means and standard deviations for the percent differences in DVtD I (kin) relative to DV,ot(e q ) mUg). The following rows show three brain levels win dowed down by a factor of 3.0 to high light areas of low binding (peak OVto, = mUg). Row 3 shows the same brain levels as row 1, whereas row 2 slices are about 3. 5 cm higher and row 4 slices are about 3.5 cm lower than those in row 3. t te sts comparing kinetic and equilibrium me thods. The ki netic me thods exhibit higher contras t between high and low bi nding re gions than the equilibrium me thod. This was especially Ill oticeable fo r the weighted integral me thod, where the normalized DV values in caudate and putamen were more than 20% greater than the equilib ri um me thod. Figure 6 gives the group me ans and across subjects standard de viations of the ra tio DVtot(kin/ DVtot(c q ) for the four-parameter least-squares and pixel by -pixel Logan plot me asures relati ve to the equilibrium me asure. The larger DVtot ratios in the higher binding de nsity regions (p utamen and caudate nucleus) than in Al though we found only relati ve ly small differences be tween kinetic and equilibrium me thods, we were in terested in examining the correspondence of the ap proaches across individual subjects as well as across dif ferent brain regions. Table 3 shows re sults from linear re gression analysis between the different me thods. Cor relation coefficients based on DVtot estimates from 45 vo lumes -of-interest (5 brain re gions from 9 subjects ) and the mean absolute difference be tween the two meth ods fo r the same 45 values are re ported to the lower le ft Intercept is given in parentheses.
of the diagonal. Correlations between the various kinetic methods are all high (over 0. 99). Correlations between the equilibrium method and each of the kinetic methods (b ottom row) are not as strong, but still range from 0. 977 and 0. 989. The weighted integral method appears to be the most different from other methods based on the mean ab solute differences between it and the other methods. Regression slopes and intercepts (in parentheses) are re ported to the upper right of the diagonal . For each re gression, the parameter in the row heading corresponds to the ordinate, whereas the parameter from the column heading corresponds to the abscissa. Thus, regressions of each of the kinetic methods on the equilibrium method f are given in the right-most column. The higher contrasts of the kinetic methods described earlier appear as regres sion slopes greater than unity. The regression between the three-compartment four-parameter kinetic method and the equilibrium method is illustrated in Fig . 7 .
The effects of study duration on DV tot estimates for both kinetic (four-parameter least-squares) and equilib rium methods are presented in Fig . 8 . Neither method depends strongly on duration. The kinetic estimates are slightly lower when using only 60 minutes of data (av eraging 1% to 5%, depending on the region), whereas equilibrium estimates (group average) differ by less than 0. 5% for all regions. The variab il ity between the 60-and 80-minute DVtot estimates across individual subjects is low, but slightly higher for the equilibrium method (4% to 5% ) than for the kinetic methods (3% to 4% ).
DISCUSSION
In previous work, we have demonstrated that the es timation of the total tissue distribution volume, DVto l' yields a precise and reliable measure of the density of binding sites for the vesicular monoamine transporter (Koeppe et aI., 1996) . Whereas the procedure is rela tively simple, requiring only a single tracer injection and 60 to 80 minutes of scanning, we were interested in testing a protocol that would be even simpler to perform and more easily tolerated by patients who may otherwise be difficult to study. Since the equil ibrium ratio of total J Cereb Blood Flow Metab, Vol. 17, No. 9. 1997 concentration of tracer in tissue to the concentration of authentic tracer in arterial plasma is the definition of DV t O l' an equilibrium protocol such as has been used by many groups in the PET field for a variety of reversible tracers is well suited for assessing the level of (+ )-a e 1 ClDTBZ binding to the vesicular monoamine trans porter. In this work, we compare results using an equi librium admin istration and analysis protocol to least squares and pixel-by-pixel kinetic approaches for estimating DVtot
The primary assumption required for the equilibrium method is that blood and tissue reach equilibrium before the initiation of scanning. If true equilibrium is not fully reached, the tissue-to-arterial plasma concentration ratio may not accurately reflect the true values of DVtot' The rates of ligand-transporter association and dissociation relative to the rate of change of the plasma concentration determine the degree of error in the DVtot estimate, as discussed by Carson and colleagues (1989) . To more rapidly achieve equilibrium conditions between plasma 
Kinetic
Equilibrium and the tissue compartments, we used a tracer adminis tration protocol consisting of a partial loading bolus fol lowed by continuous infusion of tracer. The relative frac tion of the total dose to be administered in the initial bolus depends on the clearance rate of the slowest com ponent from tissue or blood, as described previously (Fr ey et aI., 19S5, Carson et aI., 1989) . If continuous infusion alone is used or if too small a fraction is given as the loading bolus, equilibrium is delayed, since the blood and tissue concentrations must continue to climb to reach equilibrium. However, if too great a fraction is given initially, clearance of tracer must occur before reaching equilibrium. Based on the plasma clearance in the seven subjects of the initial kinetic studies reported in (Koeppe et aI., 1996) , we selected a 50:50 split between bolus and continuous admin istration fractions for the 80minute study. The average plasma clearance 30 minutes after bolus injection for these seven subjects was 0.013 min -I . Considering that a unit dose (1.0) is given as the init ial bolus and that there is approximately 1.3% clear ance per minute, 1.3% of the bolus dose per minute needs to be replaced. Thus, for a I-minute "b olus" in je ction followed by 79 minutes of continuous infusion, a total of 0.013 x 79 units of dose, or 1.03 times the dose given as a bolus, is needed to achieve equilibrium in plasma. Thus, nearly a 1: I ratio between bolus and in fu sion portions of the total dose will rapidly reach equi librium in blood. These are decay-corrected fractions, not ab solute doses, since we decay-corrected both arte rial plasma and PET data.
The first three figures demonstrate our ability to ach ie ve near equilibrium conditions by approximately 30 minutes after the loading bolus. For the particular subject shown in Figs. I and 2, there was a small net clearance in al l regions after the initial loading bolus, and, there- Ratio of DVtot derived from scan durations of 60 and 80 minutes of data for kinetic and equilibrium analy ses. Kinetic DV,ot is obtained using the four-parameter least-squares method . Data from 0 to 60 and 0 to 80 minutes were used for kinetic estimates, whereas data from 30 to 60 and 30 to 80 minutes were used for equilibrium estimates.
fore, equilibrium would have been reached more quickly with a slightly smaller bolus fraction. However, for other subjects, the higher binding regions of caudate and pu tamen demonstrated no net clearance but continued to increase for some time after the initial bolus, indicating that a slightly higher initial bolus fraction would have been better. Whereas a higher bolus fraction would delay equilibration in the lower binding regions, it is the higher binding regions that are more susceptible to errors caused by nonequilibrium conditions (Carson et aI., 1989) , and thus these are the regions that require greater attention. On the average, a 50:50 split for an 80-minute study appears to be nearly optimal. For our nine subjects, six showed trends toward in creasing concentrations, whereas three showed decreases, indicating that the op timal split varies from subject to subject (depending on individual plasma clearance rates and rate parameters for brain transport and binding). For shorter studies (e.g., 60 minutes), the fraction given as a bolus would need to be increased (since the last 20 minutes of the study is omit ted). In this case, closer to 60% of the total should be given as the loading bolus.
Data presented in Figs. 4 and 5 demonstrate that the change in input function shape for this experiment did not have a major effect on the estimates of DVtot(kin) in any of the brain regions under examination. Resu lts shown in Fig . 4 were obtained from pixel-by-pixel weighted integral analysis and showed no significant dif ferences between bolus and bolus-plus-infusion groups. Comparisons with the nonlinear least-squares and Logan plot analyses gave similar results, also yielding no sta tistically significant differences. On average, the statis tical quality of the parameter images of DVtot were slightly better for the bolus injection studies than for the bolus-plus-infusion studies. This may be due in part to the shape of the input curve producing a tissue curve with less distinct temporal changes. However, this also may result from the fact that bolus subjects received a full l8-mCi injection, whereas the bolus-plus-infusion subjects received 9 mC i as a bolus fo llowed by 9 mC i (in the syringe at time of injection) administered over the next 79 minutes. Because of decay in the syringe, only slightly greater than 3 of the final 9 mC i, or a total of 12 mCi, actually is administered to the subject. Overall, these results demonstrate that the kinetic estimates of VMA T2 binding density derived using the equilibrium acquisition protocol are consistent with kinetic estimates derived from our prev ious bolus injection protocol and, therefore, the kinetic estimates from the current study serve as a valid comparison for the equilibrium estimates derived from these same data sets.
The results presented in Table I and Fig. 5 show the distribution volume estimates from the equilibrium method to be cons istent with those from the kinetic methods. The coeffic ients of variation of the equilibrium estimates reported in Table 1 were nearly identical to those of the kinetic estimates, and, like the kinetic meth ods, exhibited almost no regional variability. The fu nc tional images in the right-most three columns of Fig . 5 demonstrate the degree of correspondence between the pixel-by-pixel kinetic and the equil ib rium methods. In dependent bb servers viewing images sets from all nine subjects rated the statistical quality of each of the three methods as being nearly identical.
The most cons istent difference among the methods was the contrast between high and low binding regions. This can be seen in the results presented in several of the tables and figures, including the subject shown in the right-most three columns of Fig . 5 . The weighted integral approach yields higher DVtot values in the basal ganglia than either the Logan or equilibrium methods (row 1, columns 3 to 5) while yielding the lowest DVtot values in the cortex, thalamus, and cerebellum (rows 2 to 4), with equilibrium images yielding the highest values. Table 2 gives binding values normalized to frontal cortex, whereas Fig. 6 shows ratios of kinetic to equilibrium DVtot estimates. Normalized DVtot in high-binding re gions of caudate nu cleus and putamen are lower for the equilibrium method than for any of the kinetic methods. However, contrast between high and low binding regions varies among the kinetic measures as well. The we ighted integral and two-parameter le ast-squares kinetic meth ods, both based on a single-tis sue model configuration, have higher contrast than the four-parameter least squares and Logan plot analyses, which are based on multicompartment configurations . The higher contrast is likely caused by the inabil ity of a two-compartment con figuration to describe (+)-a-[ I' ClDTBZ kinetics, par ticularly for regions of low binding density. Examination of the residuals from the four-parameter fits does not J Cereb Blood Flow Metab, Vol. 17, No.9, 1997 reveal a pattern that would cause overestimation in DV tot(kin) in regions of high binding density. The observed pattern of residuals, however, is cons istent with slight underestimations in DVtot(kin), particularly in regions of low binding density. This may contribute in part to the observed increase in contrast between basal ganglia and cortex in the kinetic methods.
Another factor that may explain lower DVtot values as well as lower contrast in the equilibrium method com pared with the kinetic methods is that the vascular ac tivity was ignored in the calculation of DVtot(e 'l )' The concentration measured by PET is given by (l-CBV)Ct + CBV Cbl' where CBV is the vascular fraction in brain and Ct and Cb l are the tissue and total blood concentra tions, respectively. Thus, the measured DVtot, without correctio n for vascular activity, is given by DVtot = [(1 -CBV)Ct + CBV Cb l l/C p , where C p is the authentic plasma concentration. The ratio Cb/C p approximately equals 2.0, since the red cell and plasma concentrations are nearly the same and there are about 50% metabolites. Thus, the measured DVtot is approximated by (1 -CBV) DVactual + 2 CBV, where DVactual is the correct DVtot value. For a vascular fraction of 4% and DVactual of 12 mUg (typical fo r basal ganglia), the measured DVtot would equal 11.6 mUg, an underestimation of 3.3% . For a DVactual of 4. 0 mUg (typical for cortex), the measured DVtot would equal 3.92 mUg, an underestimation of only 2%. This partly explains the lower DVtot values observed in basal ganglia and a contrast reduction of around 1.5% , but not the 5% to 7% or more reduction actually observed.
Examination of the degree to which equilibrium is achieved, as assessed by any net increase or decrease in the tissue concentration after 30 minutes, does not sup port a decrease in contrast between high and low binding regions for equilibrium analysis. Since the tissue re sponds to fluctuations in the plasma concentratio n and not the reverse, changes in the tissue concentration lag behind changes in the plasma. This lag is greater in re gions of higher binding where tissue and blood equili brate more slowly. A decline in plasma concentration causes overestimates in DVtot that are greater in higher binding regions, therefore causing contrast enhancement, whereas a slow rise in plasma concentratio n would cause the opposite. Since six of nine subjects had increases and only three of nine had gradual decreases in plasma con centration over time, we thought that we might find a difference in contrast between the two subgroups. How ever, when the subjects were separated in this manner, no differences in contrast were seen in DVtot(kin/DVtot(e q ) between basal ganglia and cortex: all nine subjects showed contrast reduction in the equilibrium analysis compared with the kinetic analyses.
Whereas the previous discussion focused on consistent biases in DVtot estimates between the methods (differ-ences in group means), we also were interested in how well equilibrium measures correlated with kinetic mea sures subject-by-subject as well as region-by-region. The results presented in Table 3 (lower left of diagonal ) dem onstrate high correlations between equilibrium and ki ne tic measures (range 0. 977 to 0. 989). The three compartment four-parameter and the Logan plot estima tions had higher correlations and also the smaller mean ab solute differe nces relative to the equil ibrium method than did the other kinetic methods, suggesting errors oc cur when using 'a two-compartment configuration, which is not fully able to describe the kinetic behavior the tracer. Correlations among the various kinetic measures were slightly higher, as might be expected, ranging from 0. 991 to 0. 997. A plot of the four-parameter DVtot(kin) versus DV1ot(e y ) estimates across the nine subjects and five regions (Fig . 7) suggests that there is greatest variability between the methods in the regions with the highest VMAT2 densities. Comparisons of the other DVtot(kin) measures with DVtot(c y ) show similar patterns, again with the greatest discrepancy being in the reg ions of highest binding . This increased variability in the high binding regions is less noticeable in plots between the various kinetic measures, and thus the slightly lower cor relation between the equilibrium and the kinetic DVtot estimates are due almost entirely to these few highest values.
The duration of data used was found to have little effect on the estimates of DVtot, as seen in Fig. 8 . This was particularly true for equilibrium estimates. We did detect small, relatively consistent differences in the ki netic methods where 60-minute DV IOI (kin) estimates were slightly lower than estimates using 80 minutes of data. These differences were greater for regions of low bind ing than regions of high binding. Examinatio n of the residuals to the kinetic fits, even when using a three compartment model configuration, typically reveals that the predicted tissue curve is slightly lower at 50 to 60 minutes than the measured data po ints. With the inclu sion of the additional 20 minutes of data, the fitted curve appears to be more cons istent with the measured data. This results in the DVtot(kin) estimates being slightly lower when only 60 compared with 80 minutes of data are used in the fit. This pattern is more noticeable in low binding regions, and therefore the effects shown in Fig .   8 are more noticeable for the thalamus, frontal cortex, and cerebellum than for the basal ganglia. The equilib rium estimates show no differences between analyses us ing 30 to 60 or 30 to 80 minutes of data, with group mean differences being less than 0. 5% in all regions. This result confirms that we have achieved equilibrium suffic iently such that data from 30 minutes and later can be used to estimate DVtot(e y )' Variability of the 60/80 minutes DVtot(e q ) ratio across ind iv idual subjects is slightly higher than for the DVtot(kin) ratio. This may likely result from the fact that only a portion of the data is used in the equilibrium calculation, compared with the entire data sequence being used for kinetic estimations , and thus statistical noise or any potential biases (such as patient motio n) in individual scans, may have a greater impact on the estimate of DVtot(e q ) than on DVtot(kin) ' Since we were interested in comparing results between kinetic and equilibrium methods, our acquisition proto col included multiple samples for both arterial plasma and brain (PET). In theory, only a single scan and single blood sample is required for calculation of DVtot, once equilibrium is achieved. However, for practical reasons, we propose that even a streamlined acquisition protocol should include multiple PET scans that are no more than 10 minutes long and blood samples approximately every 10 minutes. This protects against losing a study because of severe patient motio n part way through the scan or a bad blood sample. In our standard protocol, for deter mining DVt OI ' we now acquire three lO-minute scans from 30 to 60 minutes after the beginning of tracer ad ministration, while acquiring blood samples at 30, 40, 50, and 60 minutes.
Overall, we detected only relatively minor differences between the methods, with the equilibrium values being lowest in high binding regions. However, since no gold standard measure exists with which to compare results from any of these methods, it is difficult to assess which is most accurate. The precision was similar for all meth ods, and therefore, the choice of the most favorable method depends primarily on the specific biases associ ated with each approach. It might be predicted that the kinetic approaches would show the greatest similarity, since they all depend on data throughout the entire study, not just during the equilibrium phase. This was what we saw as indicated by the higher correlations between any combinat ion of kinetic methods (r ? 0. 991 ) than be tween the equilibrium method and any one of the kinetic methods (r � 0. 989). One might also expect that the two-parameter least-squares and weighted integral ki netic approaches show a high degree of similarity, since they both require rapid equilibration between free and bound compartments, whereas the four-parameter least squares, the Logan, and the equilibrium approaches do not require this assumption. This was not observed, but instead the weighted integral method was found to ex hibit the greatest difference from the other methods in regions of high binding, which may result from the in herent difference in how biases caused by failure of the rapid equilibration assumption propagate into the DVtot estimate for this method. Both the regression slopes (up per right of diagonal) and the mean absolute differences between methods (lower left of diagonal ) reported in Fig.  7 also suggest that the weighted integral method per forms unlike the others. In comparisons involving the weighted integral method, the regression slopes are most different from unity and the mean absolute differences are the largest.' Of the four kinetic approaches, the Logan method exhibits the highest correlations with and the smallest mean absolute differences relative to the equi librium method. Taking all of these results into account, and because of the fewer overall assumptions and inher ent greater simplicity of the approaches, we believe that the Logan calculation and the equilibrium method pro vide the most accurate measures of DVtot, although the difference in performance from the other approaches is small. Other factors, such as whether an accurate esti mate of K l is required, still may influe , nce the fi nal se lection of which method to adopt.
In summary, we have shown that an equilibrium ap proach to (+ )-a-e l C]DTBZ imaging is easily performed and the data easily analyzed. Although the experimental protocol in this study involved acquisition of a full dy namic sequence of PET scans and numerous blood samples to allow kinetic analysis, a procedure stream lined for equilibrium analysis requires only a single scan ning interval of 30 minutes or less and a few blood samples. An administration protocol consisting of a load ing bolus followed by continuous infusion can provide steady-state conditions in both blood and tissue by ap proximately 30 minutes. We have demonstrated a high degree of correspondence between kinetic and equilib rium estimates of the total (+ )-a-[ ll C]DTBZ distribution volume. The coefficients of variation of the kinetic and equilibrium DVtot estimates were nearly identical in all regions examined, both for absolute and for normalized measures. The statistical quality of data and hence the precision of the methods also appear to be similar. Cor relations between kinetic and equilibrium estimates across both subjects and regions exceeded 0. 975. A slightly lower contrast (7% to 10%) between regions of high and low VMA T2 binding density was observed for the equilibrium method compared with the kinetic meth ods; however, this difference was consistent across sub jects. We conclude that a simple protocol using a loading bolus followed by continuous infusion of (+ )-a
[llC]DTBZ can provide excellent measures of VMAT2 binding.
